00_MJ_Intro_Budapest16.pptx

Previous Page

Next Page

Page Background

ESTRO

•

Local relapse: 9/41

- No marginal recurrence (i.e. in the CTV

CT

and not CTV

PET

)

•

Regional relapse: 2/41

•

Metastasis: 6/41

•

Second primary: 2/41

Validation study in locally advanced HNSCC

Grégoire & Leclerc, 2013